Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H22O2 |
Molecular Weight | 270.3661 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O
InChI
InChIKey=MEHHPFQKXOUFFV-OWSLCNJRSA-N
InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h8-10,15-17,20H,2-7H2,1H3/t15-,16+,17+,18+/m1/s1
Molecular Formula | C18H22O2 |
Molecular Weight | 270.3661 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: description was created based on several sources, including:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de1d618f-7e27-4307-9330-0e1a2255ee95
http://www.wikidoc.org/index.php/Trenbolone
Curator's Comment: description was created based on several sources, including:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de1d618f-7e27-4307-9330-0e1a2255ee95
http://www.wikidoc.org/index.php/Trenbolone
Trenbolone is an anabolic steroid. It is used on livestock to increase muscle growth and appetite. Trenbolone compounds have a binding affinity for the androgen receptor three times as high as that of testosterone. Once metabolized, the drugs have the effect of increasing nitrogen uptake by muscles, leading to an increase in the rate of protein synthesis. It also has the secondary effects of stimulating appetite, reducing the amount of fat being deposited in the body, and decreasing the rate of catabolism. Short-term side effects include insomnia, high blood pressure, increased aggression, night sweats, and libido.
CNS Activity
Sources: http://www.ncbi.nlm.nih.gov/pubmed/25461682
Curator's Comment: Known to be CNS penetrant in rat. Human data not available.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1871 Sources: http://www.ncbi.nlm.nih.gov/pubmed/11252818 |
0.15 nM [Kd] | ||
Target ID: CHEMBL208 Sources: http://www.ncbi.nlm.nih.gov/pubmed/11252818 |
|||
Target ID: CHEMBL2034 Sources: http://www.ncbi.nlm.nih.gov/pubmed/3486322 |
53.0 nM [Kd] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Finaplix®-H Approved UseIncreases rate of weight gain and improves feed efficiency. Launch Date1987 |
Doses
Dose | Population | Adverse events |
---|---|---|
25 mg 1 times / day multiple, oral Overdose Dose: 25 mg, 1 times / day Route: oral Route: multiple Dose: 25 mg, 1 times / day Sources: |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M Food Status: UNKNOWN Sources: |
Disc. AE: jaundice, pruritus... AEs leading to discontinuation/dose reduction: jaundice (1 pt) Sources: pruritus (1 pt) |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
jaundice | 1 pt Disc. AE |
25 mg 1 times / day multiple, oral Overdose Dose: 25 mg, 1 times / day Route: oral Route: multiple Dose: 25 mg, 1 times / day Sources: |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M Food Status: UNKNOWN Sources: |
pruritus | 1 pt Disc. AE |
25 mg 1 times / day multiple, oral Overdose Dose: 25 mg, 1 times / day Route: oral Route: multiple Dose: 25 mg, 1 times / day Sources: |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M Food Status: UNKNOWN Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
[Simple and rapid analysis of trenbolone and zeranol residues in cattle muscle and liver by stack-cartridge solid-phase extraction and HPLC using on-line clean-up with EC and UV detection]. | 2001 Aug |
|
Biochemistry and physiology of anabolic hormones used for improvement of meat production. | 2001 Jan |
|
Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods. | 2001 May |
|
The fate of trenbolone acetate and melengestrol acetate after application as growth promoters in cattle: environmental studies. | 2001 Nov |
|
Sensor chip preparation and assay construction for immunobiosensor determination of beta-agonists and hormones. | 2001 Oct |
|
In vitro and in vivo effects of 17beta-trenbolone: a feedlot effluent contaminant. | 2002 Dec |
|
Determination of trenbolone and its metabolite in bovine fluids by liquid chromatography-tandem mass spectrometry. | 2003 Jan 25 |
|
Effects of the androgenic growth promoter 17-beta-trenbolone on fecundity and reproductive endocrinology of the fathead minnow. | 2003 Jun |
|
Single-laboratory validation of a modified liquid chromatographic method with UV detection for determination of trenbolone residues in bovine liver and muscle. | 2003 Sep-Oct |
|
Testosterone-stimulated weanlings as an alternative to castrated male rats in the Hershberger anti-androgen assay. | 2004 Apr |
|
Mobility of the growth promoters trenbolone and melengestrol acetate in agricultural soil: column studies. | 2004 Jun 29 |
|
Androgenic and estrogenic activity in water bodies receiving cattle feedlot effluent in Eastern Nebraska, USA. | 2004 Mar |
|
Tetrahydrogestrinone is a potent androgen and progestin. | 2004 May |
|
Detection, quantification and confirmation of anabolic steroids in equine plasma by liquid chromatography and tandem mass spectrometry. | 2005 Dec 27 |
|
Rapid test by liquid chromatography/tandem mass spectrometry to evaluate equine urine reactivity towards 17beta-OH steroids. | 2006 |
|
Collision-induced dissociation pathways of anabolic steroids by electrospray ionization tandem mass spectrometry. | 2006 Apr |
|
[Rhabdomyolysis in a bodybuilder using steroids]. | 2006 May 13 |
|
Determination of anabolic steroids in muscle tissue by liquid chromatography-tandem mass spectrometry. | 2007 Oct 17 |
|
Induction of micronuclei in V79 cells by the anabolic doping steroids tetrahydrogestrinone and trenbolone. | 2008 Apr |
|
Identification of hormone esters in injection site in muscle tissues by LC/MS/MS. | 2008 Dec |
|
Intercalibration exercise using a stickleback endocrine disrupter screening assay. | 2008 Feb |
|
[Determination of eleven steroid hormones in animal muscle tissues and eggs using ultra-performance liquid chromatography-tandem mass spectrometry]. | 2008 Nov |
|
The development of multiple drug use among anabolic-androgenic steroid users: six subjective case reports. | 2008 Nov 28 |
|
Determination of trenbolone residual in bovine liver by liquid chromatography-mass spectrometry. | 2009 Apr |
|
Expression signatures for a model androgen and antiandrogen in the fathead minnow (Pimephales promelas) ovary. | 2009 Apr 1 |
|
Stereoselective sorption by agricultural soils and liquid-liquid partitioning of trenbolone (17alpha and 17beta) and trendione. | 2009 Dec 1 |
|
The watershed as a conceptual framework for the study of environmental and human health. | 2009 Feb 18 |
|
Synthesis and SAR study of novel pseudo-steroids as potent and selective progesterone receptor antagonists. | 2009 Jul 15 |
|
Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry. | 2009 Mar |
|
Confirmatory method for the determination of nandrolone and trenbolone in urine samples using immunoaffinity cleanup and liquid chromatography-tandem mass spectrometry. | 2009 Nov 13 |
|
Analysis of anabolic steroids in hair: time courses in guinea pigs. | 2009 Sep |
|
Is the gonadotropin releasing hormone system vulnerable to endocrine disruption in birds? | 2009 Sep 1 |
|
Hormonal growth promoting agents in food producing animals. | 2010 |
|
Gonadal alterations in male eelpout (Zoarces viviparus) exposed to ethinylestradiol and trenbolone separately or in combination. | 2010 |
|
In vitro study of Organization for Economic Co-operation and Development (OECD) endocrine disruptor screening and testing methods- establishment of a recombinant rat androgen receptor (rrAR) binding assay. | 2010 Apr |
|
Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories. | 2010 Apr |
|
Synthesis and characterization of new aromatic esters based on 4,16-pregnadiene-6,20-dione skeleton. | 2010 Dec 8 |
|
Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action. | 2010 Feb 18 |
|
Sex differences in the uptake and disposition of perfluorooctanoic acid in fathead minnows after oral dosing. | 2010 Jan 1 |
|
Trenbolone causes irreversible masculinization of zebrafish at environmentally relevant concentrations. | 2010 Jul 15 |
|
Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity. | 2010 Jun |
|
Soil temperature and moisture effects on the persistence of synthetic androgen 17alpha-trenbolone, 17beta-trenbolone and trendione. | 2010 May |
|
OECD validation of phase-3 Hershberger assay using the stimulated weanling male rat in Korea. | 2010 May |
|
Assessing the fate and transformation by-product potential of trenbolone during chlorination. | 2010 Nov |
Patents
Sample Use Guides
One implant containing 200 mg trenbolone acetate is administered to each animal. The implant is placed under the skin on the posterior aspect of the ear by means of a special implanter.
Route of Administration:
Other
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/12441365
Trenbolone was a high-affinity ligand for the androgen receptor (AR), with an IC(50) of about 4 nM in rat ventral prostate cytosol and about 33 nM in cells transfected with the human AR.
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:34:21 GMT 2025
by
admin
on
Mon Mar 31 18:34:21 GMT 2025
|
Record UNII |
P53R4420TR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Trenbolone
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
||
|
CFR |
21 CFR 556.739
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
||
|
NCI_THESAURUS |
C2360
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
||
|
DEA NO. |
4000
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2916
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY | |||
|
SUB11232MIG
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY | |||
|
25015
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY | |||
|
1484278
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY | RxNorm | ||
|
P53R4420TR
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY | |||
|
P53R4420TR
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY | |||
|
TRENBOLONE
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY | |||
|
100000077481
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY | |||
|
m11015
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID0034192
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY | |||
|
DB11551
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY | |||
|
10161-33-8
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY | |||
|
CHEMBL1698011
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY | |||
|
C95072
Created by
admin on Mon Mar 31 18:34:21 GMT 2025 , Edited by admin on Mon Mar 31 18:34:21 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |